Interestingly, Sox2 is expressed by cancer stem cells (CSCs, Cancer Stem Cells, cancer cells with tumor-initiating properties) derived from pediatric brain cancers [53], and SOX2 knockdown arrests proliferation and results in a loss of tumorigenicity of glioblastoma CSCs [54]. This evidence concerns the gene SOX2 and cancer.